An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Summary

The study proposes to evaluate the safety and efficacy of PF-03715455 in moderate to severe asthma when added to standard of care and during staged withdrawal of background therapy.

Timeline

Start

2014-11

Primary completion

2015-05

Completion

2015-05

Outcome

Outcome not reported

Stopped (Business): “The termination was due to business reasons. No safety or efficacy concerns contributed to the termination of the study”

Drugs

Indications